Clinical Trials in Finland — Country Dashboard | 546 EU Studies

Filter these 546 trials by condition, phase, sponsor and more.

Open in Search →

546 Registered trials

232 Recruiting

249 Completed trials

178 Sponsors active

101 Research sites

Phase III

Phase II

Phase IV

Phase III: 287 Phase II/III: 31 Phase II: 94 Phase I/II: 21 Phase III/IV: 9 Phase IV: 66 Phase I: 10 Phase I (Other): 17 Phase I (FiH): 8 Other: 3

Oversight events in trials active here:

45 serious breaches 167 temporary halts 10 urgent safety measures 24 unexpected events 28 corrective measures across 80 trials

View oversight register →

Top conditions

Non-small cell lung cancer 10 Prostate cancer metastatic 8 Ovarian cancer 6 Obesity 5 Endometrial cancer 4 Multiple sclerosis 4 Bladder cancer 3 Non-small cell lung cancer metastatic 3 Breast cancer metastatic 3 Influenza 3 Respiratory syncytial virus infection 3 Ovarian cancer recurrent 3

Top sponsors

Merck Sharp & Dohme LLC 41 HUS-Yhtymae 30 Pfizer Inc. 25 Boehringer Ingelheim International GmbH 18 Turku University Hospital 17 Boehringer Ingelheim Espana S.A. 16 Glaxosmithkline Research & Development Limited 16 Bristol-Myers Squibb Services Unlimited Company 14 AstraZeneca AB 13 Novartis Pharma AG 13 Bayer AG 12 Pirkanmaan hyvinvointialue 12

Cities with most trials

All 30 cities →

All trials — page 8

546 total

Restarting Early versus Later Anticoagulation for Chronic Subdural Hematoma with Atrial Fibrillation (RELACS) Recruiting

2025-521179-29-00 Phase II/III Chronic subdural hematoma HUS-Yhtymae
INtravenous Contrast computed tomography versus native computed tomography in patients with acute Abdomen and impaired Renal functiOn (INCAR… Recruiting

2024-512084-31-00 Phase IV Patients requiring emergency abdominal or body CT with eGFR … University Of Helsinki
A study to test the safety and tolerability of Lu AH69593 in adults that are healthy or have narcolepsy. Recruiting

2024-511073-29-00 Phase I (Other) Narcolepsy H. Lundbeck A/S
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (… Recruiting

2023-510294-34-00 Phase III small lymphocytic lymphoma (SLL) University Of Cologne
Daratumumab in Monoclonal Gammopathy of Renal Significance in Finland, DAMOCLES Recruiting

2024-517676-37-01 Phase I (Other) Monoclonal Gammopathy of Renal Significance (MGRS) HUS-Yhtymae
Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1… Recruiting

2023-508196-36-00 Phase II Follicular lymphoma Karolinska University Hospital
A Phase I/II study of GSK5733584 in combination with anti-cancer therapies for advanced solid tumors Recruiting

2024-517147-31-00 Phase I/II Tumours, Gynecological Glaxosmithkline Research & Development Limited
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) Recruiting

2024-514937-39-00 Phase III Dravet Syndrome Longboard Pharmaceuticals Inc.
A clinical study of V940 and pembrolizumab to treat lung cancer (V940-009) Recruiting

2023-506327-29-00 Phase III Non-Small Cell Lung Cancer Merck Sharp & Dohme LLC
A first-in-human study to learn about the safety of BAY 3547926 and how well it works in participants with advanced liver cancer Recruiting

2024-516615-25-00 Phase I hepatocellular carcinoma (HCC) Bayer AG; Bayer Consumer Care AG
Pooled human plasma vs. Crystalloid in the fluid management of children undergoing instrumented spinal fusion for scoliosis. A double-blind,… Recruiting

2024-514857-31-00 Phase II Neuromuscular scoliosis (NMS) HUS-Yhtymae
A Phase 3 Study of a GPRC5D-directed CAR T Cell Therapy in Participants with Relapsed or Refractory Multiple Myeloma and Exposed to Lenalido… Recruiting

2024-515279-37-00 Phase III Relapsed or Refractory and Lenalidomide exposed Multiple Mye… Celgene Corp.
A clinical proof-of-concept study to reduce smoldering inflammation in progressive MS Recruiting

2024-517336-21-00 Phase II Progressive multiple sclerosis University Of Turku
PCA-oxycodone after cardiac surgery; respiratory effects, and short and long term outcome Recruiting

2024-515530-33-00 Phase IV coronary artery disease Aortic valve disease Mitral valve di… Pohjois-Savon hyvinvointialue
Study of MK-5684-based Therapies in Advanced Prostate Cancer Recruiting

2023-506288-33-00 Phase I/II Metastatic castration resistant prostate cancer (mCRPC) Merck Sharp & Dohme LLC
Clinical trial of molnupiravir (MK-4482) in adults who have COVID-19 and are not hospitalized, who are at high risk for serious illness from… Recruiting

2023-507227-36-00 Phase III SARS-CoV-2 (COVID-19) infection Merck Sharp & Dohme LLC
A study to test whether spesolimab helps people with a skin condition called pyoderma gangrenosum Recruiting

2024-514306-31-00 Phase III Pyoderma gangrenosum Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
C2321003: A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men with Metastatic Castration-Resistant… Recruiting

2024-511652-40-00 Phase III METASTATIC CASTRATION RESISTANT PROSTATE CANCER Pfizer Inc.
PRO_RSTAP study: Effect of medial transversus abdominis plane (TAP) block and rectus sheath block on inguinal hernia surgery recovery, a pro… Recruiting

2024-513406-59-00 Phase III Inguinal hernia open surgery recovery Pirkanmaan hyvinvointialue
EWALL-PH-03: An open label, 2-arm, Randomised phase II study to Compare the Safety and Efficacy of Ponatinib plus Chemotherapy with Imatinib… Recruiting

2023-505330-95-01 Phase II Blood cancer Cardiff University
RAXO trial - A population-based prospective study to evaluate clinical behaviour, resectability and survival in metastatic colorectal cancer… Recruiting

2024-520288-15-00 Phase IV Metastatic or locally advanced inoperable colorectal cancer HUS-Yhtymae
Monitoring of neuromuscular blockade during general anaesthesia Recruiting

2024-517831-28-00 Phase IV Incidence of reappearance of the muscle relaxation after rev… Pirkanmaan hyvinvointialue
A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy Recruiting

2023-508813-18-00 Phase II Refractory Focal Onset Epilepsy Biohaven Therapeutics Ltd.
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subject… Recruiting

2024-513860-25-00 Phase I/II Ovarian Neoplasms Glaxosmithkline Research & Development Limited

Showing 169–192 of 546 trials

← All countries